Open AccessFirst case of mirtazepine-induced Stevens-Johnson syndrome from India
Author(s) -
Amit Bhasin,
Anil Gurtoo,
Latika Gupta,
Gunjan Aggarwal
Publication year - 2012
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.100411
Subject(s) - exacerbation , mucocutaneous zone , dermatology , medicine , adverse effect , lupus erythematosus , pathology , immunology , disease , antibody
A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were suggestive of Stevens-Johnson syndrome. This is a rare adverse effect of the newer generation antidepressant mirtazepine.